BUFORNIN 1 AS A SPECIFIC INHIBITOR AND THERAPEUTIC AGENT FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS - Patent 1179022

(19)

(11)

EP 1 179 022 A2

(12)

(88)	Date of publication A3:
	09.08.2001

(43)	Date of publication:
	13.02.2002 Bulletin 2002/07

(21)	Application number: 00948495.7

(22)	Date of filing: 11.05.2000

(51)	International Patent Classification (IPC)⁷: C07K 14/81, A61K 38/55, A61P 39/00, C12N 15/63, C12N 5/10

(86)	International application number:
	PCT/US0012/909

(87)	International publication number:
	WO 0069/895 (23.11.2000 Gazette 2000/47)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

14.05.1999 US 134216 P

(71)	Applicant: Department of the Army
	Fort Detrick, MD 21702-5012 (US)

(72)	Inventors:
	GARCIA, Gregory, E. (US) GORDON, Richard, K. Potomac, MD 20854 (US) MOORAD, Deborah, R. Rockville MD 20850-3552 (US) DOCTOR, Bhupendra, P. Potomac, MD 20854 (US)

(74)	Representative: Sexton, Jane Helen
	J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(54)	BUFORNIN 1 AS A SPECIFIC INHIBITOR AND THERAPEUTIC AGENT FOR BOTULINUM TOXIN B AND TETANUS NEUROTOXINS